C30H35N7O4S
589.7 g/mol
APIDanger
Imatinib mesylate
CAS220127-57-1
Category
API
Compound Class
Other
Primary Use
Pharmaceutical Raw Material
Imatinib mesylate is the mesylate salt form of imatinib, a small-molecule tyrosine kinase inhibitor used as an active pharmaceutical ingredient in targeted cancer therapy.
pharmaceutical raw material for tyrosine kinase inhibitor formulationscompound used in manufacturing of oral targeted cancer therapies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 220127-57-1
Related Compounds
StrongSame Parent
Imatinib
CAS152459-95-5
pharmaceutical raw material
SimilarStructure SimilarSimilarity 0.85
N-Desmethyl N-Nitroso Imatinib
CAS2816369-80-7
research compound
SimilarStructure SimilarSimilarity 0.85
Cgp-74588
CAS404844-02-6
pharmaceutical raw material
SimilarStructure SimilarSimilarity 0.81
4-[(4-Methyl-4-oxo-4λ⁵-piperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide
CAS571186-91-9
pharmaceutical raw material
ReferenceSame Category
Levocloperastine fendizoate
CAS220329-19-1
pharmaceutical raw material
ReferenceSame Category
AR-C124910XX
CAS220347-05-7
pharmaceutical raw material
ReferenceSame Category
(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R,3R)-2,3-dihydroxybutanedioate
CAS220352-39-6
pharmaceutical raw material
ReferenceSame Category
Orobanchol
CAS220493-64-1
pharmaceutical raw material
Safety Reference
Danger
H302Harmful if swallowed
H351Suspected of causing cancer
H360May damage fertility or the unborn child
Identifiers
IUPAC Name
methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
InChIKey
YLMAHDNUQAMNNX-UHFFFAOYSA-N
SMILES
CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O
Synonyms (53)
- IMKELDI
- Imatinib mesylate (USAN)
- 220127-57-1 (mesylate)
- CGP 57148B
- Genfatinib
- Gleevac
- Gleevec
- Gleevec (Imatinib mesylate)
- Gleevec (TN)
- Glivec
- Glivec (TN)
- IMATINIB MESILATE [MART.]
- Imatinib (as mesilate)
- Imatinib Mesylate (STI571)
- Imatinib Mesylate Tablets
- Imatinib Mesylate(|A form)
- Imatinib Methansulfonate
- Imatinib accord
- Imatinib medac
- Imatinib mesilate
- Imatinib mesilate (JAN)
- Imatinib mesilate CRS
- Imatinib mesylate
- Imatinib mesylate 400 mg
- Imatinib monomethanesulfonate
- Imatinib(free base)?
- Mesylate, Imatinib
- Methanesulfonate, Imatinib
- ST-1571 Mesylate
- Shantinib
- imatinib methanesulfonate
- imatinib monomesylate
- imatinib oral